checkAd

     197  0 Kommentare Vaxart Appoints David Wheadon, M.D., to its Board of Directors - Seite 3

    Contacts
      Media Relations:
    Gloria Gasaatura
    LifeSci Communications
    (646) 970- 4688
    ggasaatura@lifescicomms.com
    Investor Relations:
    David R. Holmes
    LifeSci Advisors, LLC
    (646) 970-4995
    dholmes@lifesciadvisors.com

    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Vaxart Appoints David Wheadon, M.D., to its Board of Directors - Seite 3 SOUTH SAN FRANCISCO, Calif., April 23, 2021 (GLOBE NEWSWIRE) - Vaxart, Inc. (Nasdaq: VXRT), a clinical-stage biotechnology company developing oral recombinant vaccines that are administered by tablet rather than by injection, today announced the …